CLINICAL DOSING: "The daily intake of AOD9604 in dosages of 0.5-1 mg/day over 24-weeks can be stated as being safe and well tolerated."
For localized topical effects, once or twice daily is standard
Cleveland Clinic, in its explanation of how gut and appetite hormones such as GLP-1 regulate fullness, describes the same hormone-driven hunger signaling that cagrilintide targets through the parallel amylin pathway
[4] Sikiric, P., Seiwerth, S., Brcic, L., & Kolenc, D
This allows for lower, more effective doses while minimizing gastrointestinal side effects commonly associated with standard berberine
Tumor Promotion: The Most Debated Serious Risk The angiogenic properties of BPC-157 are well-documented in rodent wound-healing models